| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 1440899
[patent_doc_number] => 06335193
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-01-01
[patent_title] => 'Isolated colonocytes'
[patent_app_type] => B1
[patent_app_number] => 09/292358
[patent_app_country] => US
[patent_app_date] => 1999-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4369
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/335/06335193.pdf
[firstpage_image] =>[orig_patent_app_number] => 09292358
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/292358 | Isolated colonocytes | Apr 14, 1999 | Issued |
| 09/288359 | RENAL CELL CARCINOMA TREATMENT | Apr 7, 1999 | Abandoned |
Array
(
[id] => 5800776
[patent_doc_number] => 20020009417
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-24
[patent_title] => 'NUCLEOSOME-BASED ANTI-TUMOR COMPOSITIONS'
[patent_app_type] => new
[patent_app_number] => 09/286268
[patent_app_country] => US
[patent_app_date] => 1999-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6304
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20020009417.pdf
[firstpage_image] =>[orig_patent_app_number] => 09286268
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/286268 | NUCLEOSOME-BASED ANTI-TUMOR COMPOSITIONS | Apr 4, 1999 | Abandoned |
| 09/280456 | TUMOR THERAPY | Mar 29, 1999 | Abandoned |
| 09/268787 | HYBRID WITH INTERFERON-A AND AN IMMUNOGLOBULIN FC FOR TREATMENT OF TUMORS | Mar 15, 1999 | Abandoned |
| 09/260978 | ISOLATED NUCLEIC ACID MOLECULES ENCODING MAGE GENES AND USES THEREOF | Mar 1, 1999 | Abandoned |
Array
(
[id] => 1459067
[patent_doc_number] => 06391630
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-05-21
[patent_title] => 'Plasmids that encode green fluorescent protein'
[patent_app_type] => B1
[patent_app_number] => 09/260420
[patent_app_country] => US
[patent_app_date] => 1999-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8383
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/391/06391630.pdf
[firstpage_image] =>[orig_patent_app_number] => 09260420
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/260420 | Plasmids that encode green fluorescent protein | Feb 28, 1999 | Issued |
Array
(
[id] => 6361036
[patent_doc_number] => 20020058609
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-16
[patent_title] => 'COMPOSITIONS AND METHODS USING COMPLEXES OF CALRETICULIN AND ANTIGENIC MOLECULES'
[patent_app_type] => new
[patent_app_number] => 09/261473
[patent_app_country] => US
[patent_app_date] => 1999-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 17127
[patent_no_of_claims] => 157
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20020058609.pdf
[firstpage_image] =>[orig_patent_app_number] => 09261473
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/261473 | COMPOSITIONS AND METHODS USING COMPLEXES OF CALRETICULIN AND ANTIGENIC MOLECULES | Feb 25, 1999 | Abandoned |
Array
(
[id] => 4271898
[patent_doc_number] => 06307036
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-23
[patent_title] => 'Tumour suppressor gene'
[patent_app_type] => 1
[patent_app_number] => 9/257580
[patent_app_country] => US
[patent_app_date] => 1999-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 4028
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/307/06307036.pdf
[firstpage_image] =>[orig_patent_app_number] => 257580
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/257580 | Tumour suppressor gene | Feb 24, 1999 | Issued |
| 09/255947 | TUMOR SUPPRESSOR GENE DEL-27 | Feb 22, 1999 | Abandoned |
| 09/255381 | GENES ASSOCAITED WITH DISEASES OF THE COLON | Feb 21, 1999 | Abandoned |
Array
(
[id] => 6275708
[patent_doc_number] => 20020106627
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-08
[patent_title] => 'METHODS OF SCREENING COMPOUNDS FOR BIOACTIVITY IN ORGANIZED TISSUE'
[patent_app_type] => new
[patent_app_number] => 09/252324
[patent_app_country] => US
[patent_app_date] => 1999-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12741
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20020106627.pdf
[firstpage_image] =>[orig_patent_app_number] => 09252324
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/252324 | METHODS OF SCREENING COMPOUNDS FOR BIOACTIVITY IN ORGANIZED TISSUE | Feb 17, 1999 | Abandoned |
Array
(
[id] => 457014
[patent_doc_number] => 07244826
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-07-17
[patent_title] => 'Internalizing ERB2 antibodies'
[patent_app_type] => utility
[patent_app_number] => 09/250056
[patent_app_country] => US
[patent_app_date] => 1999-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 28690
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/244/07244826.pdf
[firstpage_image] =>[orig_patent_app_number] => 09250056
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/250056 | Internalizing ERB2 antibodies | Feb 11, 1999 | Issued |
Array
(
[id] => 4333348
[patent_doc_number] => 06313277
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-11-06
[patent_title] => 'Breast cancer resistance protein (BCRP) and the DNA which encodes it'
[patent_app_type] => 1
[patent_app_number] => 9/245808
[patent_app_country] => US
[patent_app_date] => 1999-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 27
[patent_no_of_words] => 10776
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/313/06313277.pdf
[firstpage_image] =>[orig_patent_app_number] => 245808
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/245808 | Breast cancer resistance protein (BCRP) and the DNA which encodes it | Feb 4, 1999 | Issued |
Array
(
[id] => 4271884
[patent_doc_number] => 06307035
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-23
[patent_title] => 'BRCA1 associated polynucleotide (BAP-1) and uses therefor'
[patent_app_type] => 1
[patent_app_number] => 9/230196
[patent_app_country] => US
[patent_app_date] => 1999-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 23354
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/307/06307035.pdf
[firstpage_image] =>[orig_patent_app_number] => 230196
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/230196 | BRCA1 associated polynucleotide (BAP-1) and uses therefor | Jan 19, 1999 | Issued |
| 09/234290 | TREATMENT FOR INSULIN DEPENDENT DIABETES | Jan 19, 1999 | Abandoned |
Array
(
[id] => 899600
[patent_doc_number] => 07338767
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2008-03-04
[patent_title] => 'Use of microphthalmia for diagnosis, prognosis and/or treatment of melanoma'
[patent_app_type] => utility
[patent_app_number] => 09/229283
[patent_app_country] => US
[patent_app_date] => 1999-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 20
[patent_no_of_words] => 11456
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/338/07338767.pdf
[firstpage_image] =>[orig_patent_app_number] => 09229283
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/229283 | Use of microphthalmia for diagnosis, prognosis and/or treatment of melanoma | Jan 12, 1999 | Issued |
Array
(
[id] => 6999924
[patent_doc_number] => 20010053371
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-12-20
[patent_title] => 'METHOD FOR DIAGNOSING, IMAGING, AND TREATING TUMORS USING RESTRICTIVE RECEPTOR FOR INTERLEUKIN 13'
[patent_app_type] => new
[patent_app_number] => 09/226794
[patent_app_country] => US
[patent_app_date] => 1999-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7353
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20010053371.pdf
[firstpage_image] =>[orig_patent_app_number] => 09226794
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/226794 | METHOD FOR DIAGNOSING, IMAGING, AND TREATING TUMORS USING RESTRICTIVE RECEPTOR FOR INTERLEUKIN 13 | Jan 6, 1999 | Abandoned |
Array
(
[id] => 4032657
[patent_doc_number] => 05942402
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-08-24
[patent_title] => 'Method of detecting and treating cancer'
[patent_app_type] => 1
[patent_app_number] => 9/226548
[patent_app_country] => US
[patent_app_date] => 1999-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5315
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/942/05942402.pdf
[firstpage_image] =>[orig_patent_app_number] => 226548
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/226548 | Method of detecting and treating cancer | Jan 6, 1999 | Issued |
| 09/226075 | THERAPEUTIC LIPOSOME-ENCAPSULATED IMMUNOMODULATORS | Jan 5, 1999 | Abandoned |